Table 1.
The number of toxin EIA samples against a selection of NAAT CT value ranges with patient mortality within 1 month and 3 months
| CT Value | EIA Toxin Positive a | Total EIA b | Mortality/month c | Mortality/3 months c |
|---|---|---|---|---|
| 18 | 1 (100%) | 1 | 1 | 1 |
| 19 | 4 (80%) | 5 | 2 | 2 |
| 20 | 32 (84%) | 38 | 7 | 12 |
| 21 | 80 (85%) | 94 | 17 | 25 |
| 22 | 113 (80%) | 140 | 16 | 29 |
| 23 | 119 (72%) | 166 | 23 | 31 |
| 24 | 106 (67%) | 157 | 27 | 39 |
| 25 | 96 (56%) | 171 | 21 | 34 |
| 26 | 63 (50%) | 125 | 12 | 19 |
| 27 | 52 (37%) | 139 | 19 | 34 |
| 28 | 24 (27%) | 89 | 7 | 13 |
| 29 | 23 (24%) | 95 | 10 | 16 |
| 30 | 17 (20%) | 83 | 8 | 16 |
| 31–37 | 24 (7%) | 347 | 41 | 60 |
| All | 754 (46%) | 1650 | 210 | 331 |
| 18–25 | 551 (72%) | 772 | 113 | 173 |
| 26–37 | 203 (23%) | 878 | 97 | 158 |
a All samples are GDH, NAAT and toxin A and B EIA positive
b Total number of toxin A and B EIAs undertaken from GDH and NAAT positive samples including both negative and positive results for toxin A and B
c Reflects the number of patients with 1 month or 3-month mortality